Click for best price
Arthritis Drug Market Size, Share 2023
Arthritis is condition that causes pain and inflammation in joints. Around 100 different types of arthritis related conditions present globally and it is one of the leading cause of disability worldwide. The most common types of arthritis includes: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, are among others.
This report aims to provide a comprehensive presentation of the global market for Arthritis Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Arthritis Drug. This report contains market size and forecasts of Arthritis Drug in global, including the following market information:
Global Arthritis Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Arthritis Drug Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Arthritis Drug companies in 2022 (%)
The global Arthritis Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Growing burden of incidence of osteoarthritis, psoriatic arthritis and rheumatoid arthritis patients are major factors driving the growth of global arthritis drugs market. According to CDC estimation from 2010-2012, about 52.5 million US adults had some form of arthritis conditions among them persons with age 65 or older reported higher prevalence of arthritis conditions than the other ages due to ?wear and tear? on the joints. However, due to lack of proper medication to cure arthritis and higher cost of the medications are hindering the growth of this market over the forecast period.
We surveyed the Arthritis Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Arthritis Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Arthritis Drug Market Segment Percentages, by Type, 2022 (%)
Synthetic DMARDs
Biological DMARDs
NSAIDs
Corticosteroids
Analgesics
Global Arthritis Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Arthritis Drug Market Segment Percentages, by Application, 2022 (%)
Retail Pharmacies
Hospital Pharmacies
Drug Stores
E-Commerce
Global Arthritis Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Arthritis Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Arthritis Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Arthritis Drug revenues share in global market, 2022 (%)
Key companies Arthritis Drug sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Arthritis Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Eli Lilly
Celltrion
F. Hoffmann-La Roche
Pfizer
Johnson & Johnson
GSK
Outline of Major Chapters:
Chapter 1: Introduces the definition of Arthritis Drug, market overview.
Chapter 2: Global Arthritis Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Arthritis Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Arthritis Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Arthritis Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Arthritis Drug Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
78 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Arthritis Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Arthritis Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Arthritis Drug Overall Market Size
2.1 Global Arthritis Drug Market Size: 2022 VS 2029
2.2 Global Arthritis Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Arthritis Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Arthritis Drug Players in Global Market
3.2 Top Global Arthritis Drug Companies Ranked by Revenue
3.3 Global Arthritis Drug Revenue by Companies
3.4 Global Arthritis Drug Sales by Companies
3.5 Global Arthritis Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Arthritis Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Arthritis Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Arthritis Drug Players in Global Market
3.8.1 List of Global Tier 1 Arthritis Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Arthritis Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Arthritis Drug Market Size Markets, 2022 & 2029
4.1.2 Synthetic DMARDs
4.1.3 Biological DMARDs
4.1.4 NSAIDs
4.1.5 Corticosteroids
4.1.6 Analgesics
4.2 By Type - Global Arthritis Drug Revenue & Forecasts
4.2.1 By Type - Global Arthritis Drug Revenue, 2018-2023
4.2.2 By Type - Global Arthritis Drug Revenue, 2024-2029
4.2.3 By Type - Global Arthritis Drug Revenue Market Share, 2018-2029
4.3 By Type - Global Arthritis Drug Sales & Forecasts
4.3.1 By Type - Global Arthritis Drug Sales, 2018-2023
4.3.2 By Type - Global Arthritis Drug Sales, 2024-2029
4.3.3 By Type - Global Arthritis Drug Sales Market Share, 2018-2029
4.4 By Type - Global Arthritis Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Arthritis Drug Market Size, 2022 & 2029
5.1.2 Retail Pharmacies
5.1.3 Hospital Pharmacies
5.1.4 Drug Stores
5.1.5 E-Commerce
5.2 By Application - Global Arthritis Drug Revenue & Forecasts
5.2.1 By Application - Global Arthritis Drug Revenue, 2018-2023
5.2.2 By Application - Global Arthritis Drug Revenue, 2024-2029
5.2.3 By Application - Global Arthritis Drug Revenue Market Share, 2018-2029
5.3 By Application - Global Arthritis Drug Sales & Forecasts
5.3.1 By Application - Global Arthritis Drug Sales, 2018-2023
5.3.2 By Application - Global Arthritis Drug Sales, 2024-2029
5.3.3 By Application - Global Arthritis Drug Sales Market Share, 2018-2029
5.4 By Application - Global Arthritis Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Arthritis Drug Market Size, 2022 & 2029
6.2 By Region - Global Arthritis Drug Revenue & Forecasts
6.2.1 By Region - Global Arthritis Drug Revenue, 2018-2023
6.2.2 By Region - Global Arthritis Drug Revenue, 2024-2029
6.2.3 By Region - Global Arthritis Drug Revenue Market Share, 2018-2029
6.3 By Region - Global Arthritis Drug Sales & Forecasts
6.3.1 By Region - Global Arthritis Drug Sales, 2018-2023
6.3.2 By Region - Global Arthritis Drug Sales, 2024-2029
6.3.3 By Region - Global Arthritis Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Arthritis Drug Revenue, 2018-2029
6.4.2 By Country - North America Arthritis Drug Sales, 2018-2029
6.4.3 US Arthritis Drug Market Size, 2018-2029
6.4.4 Canada Arthritis Drug Market Size, 2018-2029
6.4.5 Mexico Arthritis Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Arthritis Drug Revenue, 2018-2029
6.5.2 By Country - Europe Arthritis Drug Sales, 2018-2029
6.5.3 Germany Arthritis Drug Market Size, 2018-2029
6.5.4 France Arthritis Drug Market Size, 2018-2029
6.5.5 U.K. Arthritis Drug Market Size, 2018-2029
6.5.6 Italy Arthritis Drug Market Size, 2018-2029
6.5.7 Russia Arthritis Drug Market Size, 2018-2029
6.5.8 Nordic Countries Arthritis Drug Market Size, 2018-2029
6.5.9 Benelux Arthritis Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Arthritis Drug Revenue, 2018-2029
6.6.2 By Region - Asia Arthritis Drug Sales, 2018-2029
6.6.3 China Arthritis Drug Market Size, 2018-2029
6.6.4 Japan Arthritis Drug Market Size, 2018-2029
6.6.5 South Korea Arthritis Drug Market Size, 2018-2029
6.6.6 Southeast Asia Arthritis Drug Market Size, 2018-2029
6.6.7 India Arthritis Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Arthritis Drug Revenue, 2018-2029
6.7.2 By Country - South America Arthritis Drug Sales, 2018-2029
6.7.3 Brazil Arthritis Drug Market Size, 2018-2029
6.7.4 Argentina Arthritis Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Arthritis Drug Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Arthritis Drug Sales, 2018-2029
6.8.3 Turkey Arthritis Drug Market Size, 2018-2029
6.8.4 Israel Arthritis Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Arthritis Drug Market Size, 2018-2029
6.8.6 UAE Arthritis Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Arthritis Drug Major Product Offerings
7.1.4 Novartis Arthritis Drug Sales and Revenue in Global (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Eli Lilly
7.2.1 Eli Lilly Company Summary
7.2.2 Eli Lilly Business Overview
7.2.3 Eli Lilly Arthritis Drug Major Product Offerings
7.2.4 Eli Lilly Arthritis Drug Sales and Revenue in Global (2018-2023)
7.2.5 Eli Lilly Key News & Latest Developments
7.3 Celltrion
7.3.1 Celltrion Company Summary
7.3.2 Celltrion Business Overview
7.3.3 Celltrion Arthritis Drug Major Product Offerings
7.3.4 Celltrion Arthritis Drug Sales and Revenue in Global (2018-2023)
7.3.5 Celltrion Key News & Latest Developments
7.4 F. Hoffmann-La Roche
7.4.1 F. Hoffmann-La Roche Company Summary
7.4.2 F. Hoffmann-La Roche Business Overview
7.4.3 F. Hoffmann-La Roche Arthritis Drug Major Product Offerings
7.4.4 F. Hoffmann-La Roche Arthritis Drug Sales and Revenue in Global (2018-2023)
7.4.5 F. Hoffmann-La Roche Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Arthritis Drug Major Product Offerings
7.5.4 Pfizer Arthritis Drug Sales and Revenue in Global (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Arthritis Drug Major Product Offerings
7.6.4 Johnson & Johnson Arthritis Drug Sales and Revenue in Global (2018-2023)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 GSK
7.7.1 GSK Company Summary
7.7.2 GSK Business Overview
7.7.3 GSK Arthritis Drug Major Product Offerings
7.7.4 GSK Arthritis Drug Sales and Revenue in Global (2018-2023)
7.7.5 GSK Key News & Latest Developments
8 Global Arthritis Drug Production Capacity, Analysis
8.1 Global Arthritis Drug Production Capacity, 2018-2029
8.2 Arthritis Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Arthritis Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Arthritis Drug Supply Chain Analysis
10.1 Arthritis Drug Industry Value Chain
10.2 Arthritis Drug Upstream Market
10.3 Arthritis Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Arthritis Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Arthritis Drug in Global Market
Table 2. Top Arthritis Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Arthritis Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Arthritis Drug Revenue Share by Companies, 2018-2023
Table 5. Global Arthritis Drug Sales by Companies, (K Units), 2018-2023
Table 6. Global Arthritis Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Arthritis Drug Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Arthritis Drug Product Type
Table 9. List of Global Tier 1 Arthritis Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Arthritis Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Arthritis Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Arthritis Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Arthritis Drug Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Arthritis Drug Sales (K Units), 2018-2023
Table 15. By Type - Global Arthritis Drug Sales (K Units), 2024-2029
Table 16. By Application ? Global Arthritis Drug Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Arthritis Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Arthritis Drug Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Arthritis Drug Sales (K Units), 2018-2023
Table 20. By Application - Global Arthritis Drug Sales (K Units), 2024-2029
Table 21. By Region ? Global Arthritis Drug Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Arthritis Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Arthritis Drug Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Arthritis Drug Sales (K Units), 2018-2023
Table 25. By Region - Global Arthritis Drug Sales (K Units), 2024-2029
Table 26. By Country - North America Arthritis Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Arthritis Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Arthritis Drug Sales, (K Units), 2018-2023
Table 29. By Country - North America Arthritis Drug Sales, (K Units), 2024-2029
Table 30. By Country - Europe Arthritis Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Arthritis Drug Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Arthritis Drug Sales, (K Units), 2018-2023
Table 33. By Country - Europe Arthritis Drug Sales, (K Units), 2024-2029
Table 34. By Region - Asia Arthritis Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Arthritis Drug Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Arthritis Drug Sales, (K Units), 2018-2023
Table 37. By Region - Asia Arthritis Drug Sales, (K Units), 2024-2029
Table 38. By Country - South America Arthritis Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Arthritis Drug Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Arthritis Drug Sales, (K Units), 2018-2023
Table 41. By Country - South America Arthritis Drug Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Arthritis Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Arthritis Drug Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Arthritis Drug Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Arthritis Drug Sales, (K Units), 2024-2029
Table 46. Novartis Company Summary
Table 47. Novartis Arthritis Drug Product Offerings
Table 48. Novartis Arthritis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Eli Lilly Company Summary
Table 51. Eli Lilly Arthritis Drug Product Offerings
Table 52. Eli Lilly Arthritis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Eli Lilly Key News & Latest Developments
Table 54. Celltrion Company Summary
Table 55. Celltrion Arthritis Drug Product Offerings
Table 56. Celltrion Arthritis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Celltrion Key News & Latest Developments
Table 58. F. Hoffmann-La Roche Company Summary
Table 59. F. Hoffmann-La Roche Arthritis Drug Product Offerings
Table 60. F. Hoffmann-La Roche Arthritis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. F. Hoffmann-La Roche Key News & Latest Developments
Table 62. Pfizer Company Summary
Table 63. Pfizer Arthritis Drug Product Offerings
Table 64. Pfizer Arthritis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Pfizer Key News & Latest Developments
Table 66. Johnson & Johnson Company Summary
Table 67. Johnson & Johnson Arthritis Drug Product Offerings
Table 68. Johnson & Johnson Arthritis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Johnson & Johnson Key News & Latest Developments
Table 70. GSK Company Summary
Table 71. GSK Arthritis Drug Product Offerings
Table 72. GSK Arthritis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. GSK Key News & Latest Developments
Table 74. Arthritis Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 75. Global Arthritis Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 76. Global Arthritis Drug Production by Region, 2018-2023 (K Units)
Table 77. Global Arthritis Drug Production by Region, 2024-2029 (K Units)
Table 78. Arthritis Drug Market Opportunities & Trends in Global Market
Table 79. Arthritis Drug Market Drivers in Global Market
Table 80. Arthritis Drug Market Restraints in Global Market
Table 81. Arthritis Drug Raw Materials
Table 82. Arthritis Drug Raw Materials Suppliers in Global Market
Table 83. Typical Arthritis Drug Downstream
Table 84. Arthritis Drug Downstream Clients in Global Market
Table 85. Arthritis Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Arthritis Drug Segment by Type in 2022
Figure 2. Arthritis Drug Segment by Application in 2022
Figure 3. Global Arthritis Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Arthritis Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Arthritis Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. Arthritis Drug Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Arthritis Drug Revenue in 2022
Figure 9. By Type - Global Arthritis Drug Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Arthritis Drug Revenue Market Share, 2018-2029
Figure 11. By Type - Global Arthritis Drug Sales Market Share, 2018-2029
Figure 12. By Type - Global Arthritis Drug Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Arthritis Drug Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Arthritis Drug Revenue Market Share, 2018-2029
Figure 15. By Application - Global Arthritis Drug Sales Market Share, 2018-2029
Figure 16. By Application - Global Arthritis Drug Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Arthritis Drug Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Arthritis Drug Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Arthritis Drug Revenue Market Share, 2018-2029
Figure 20. By Region - Global Arthritis Drug Sales Market Share, 2018-2029
Figure 21. By Country - North America Arthritis Drug Revenue Market Share, 2018-2029
Figure 22. By Country - North America Arthritis Drug Sales Market Share, 2018-2029
Figure 23. US Arthritis Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Arthritis Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Arthritis Drug Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Arthritis Drug Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Arthritis Drug Sales Market Share, 2018-2029
Figure 28. Germany Arthritis Drug Revenue, (US$, Mn), 2018-2029
Figure 29. France Arthritis Drug Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Arthritis Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Arthritis Drug Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Arthritis Drug Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Arthritis Drug Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Arthritis Drug Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Arthritis Drug Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Arthritis Drug Sales Market Share, 2018-2029
Figure 37. China Arthritis Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Arthritis Drug Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Arthritis Drug Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Arthritis Drug Revenue, (US$, Mn), 2018-2029
Figure 41. India Arthritis Drug Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Arthritis Drug Revenue Market Share, 2018-2029
Figure 43. By Country - South America Arthritis Drug Sales Market Share, 2018-2029
Figure 44. Brazil Arthritis Drug Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Arthritis Drug Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Arthritis Drug Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Arthritis Drug Sales Market Share, 2018-2029
Figure 48. Turkey Arthritis Drug Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Arthritis Drug Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Arthritis Drug Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Arthritis Drug Revenue, (US$, Mn), 2018-2029
Figure 52. Global Arthritis Drug Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Arthritis Drug by Region, 2022 VS 2029
Figure 54. Arthritis Drug Industry Value Chain
Figure 55. Marketing Channels
